| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $658K | -10.4% |
| SG&A Expense | $1.5M | +16.9% |
| Operating Income | -$2.1M | -6.9% |
| Interest Expense | $31K | +0.0% |
| Pre-tax Income | -$2.9M | +2.5% |
| Net Income | -$2.9M | +2.5% |
| EPS (Basic) | -$0.08 | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8K | -97.5% |
| Inventory | $50K | +0.0% |
| Current Assets | $70K | -82.1% |
| Total Assets | $333K | -53.1% |
| Current Liabilities | $2.0M | +179.0% |
| Long-term Debt | $2.3M | — |
| Total Liabilities | $2.2M | +129.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | -3.2% |
| Capital Expenditures | $860 | -97.1% |
| Investing Cash Flow | -$860 | +97.1% |
| Financing Cash Flow | $1.5M | -27.3% |
| Free Cash Flow | -$1.8M | -1.5% |
| Stockholders' Equity |
| -$1.9M |
| -619.3% |